2014
Worldwide, stroke is the leading cause of disability in the aging population. Neuroinflammation is a common feature of acute stroke (…)
Consulter 
2015
Consulter
2015
Despite the effectiveness of recombinant tissue-type plasminogen activator (r-tPA) during the acute phase of ischemic stroke, the therapy remains limited (…)
Consulter
2015
Factor VII activating protease (FSAP) is a circulating protease with a putative role in hemostasis, remodeling and inflammation. A polymorphism (…)
Consulter
2015
Tissue-type plasminogen activator (tPA) is the only acute treatment for ischemic stroke. Unfortunately, the benefit of tPA-driven thrombolysis is not (…)
Consulter
2015
Numerous treatments have been reported to provide a beneficial outcome in experimental animal stroke models; however, these treatments (with the (…)
Consulter
